BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study

BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study

Submitted by admin on March 6, 2023 - 11:09am
Source: 
Investors Business Daily
News Tags: 
BridgeBio
dwarfism
infigratinib
achondroplasia
Headline: 
BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study
snippet: 

BridgeBio Pharma (BBIO) smashed Wall Street's expectations in a study of children with dwarfism, leading BBIO stock to break out in massive volume.

Do Not Allow Advertisers to Use My Personal information